FY24→FY25: Total +₹12.4 Cr (+3.1%) · IP flat +₹1.3 Cr · OP +₹11.1 Cr (+11.2%) · Discharges +91 (+0.4%) · ARPOB +₹1,539 (+4.8%) · ALOS -0.17d FY25→FY26e: Ann.estimate ~₹457 Cr (+11.4%) · IP growing · OP accelerating · Insurance mix +2.4pp · ARPOB +₹1,774 (+5.3%) · ALOS -0.24d
Monthly Revenue — FY25 vs FY24 Delta (₹ Crore)
Green = improvement over prior year month
Monthly Revenue — FY26 vs FY25 Delta (₹ Crore)
Apr–Jan comparison (10 available months)
Department Revenue YoY — FY24 vs FY25 vs FY26 YTD
Common departments across all 3 years (₹ Crore) · Sorted by FY26 total
Doctor Revenue Continuity — FY24 → FY25 → FY26
Doctors present in all 3 years · Revenue in ₹ Crore
#
Doctor
Dept
FY24 ₹Cr
FY25 ₹Cr
FY26 ₹Cr
FY24→25 Δ%
FY25→26 Δ%
Trend
⚠ Concentration Risk Analysis
FY26 YTD: Top 2 doctors = ₹84.8 Cr = 22.3% of ₹381 Cr revenue (Gangadharan VP ₹52.9 Cr + Abi Abraham M ₹31.9 Cr).
Top 5 = 36.3%. Top 10 = 51.2%. Single-doctor departure risk is acute in Medical Oncology and Nephrology.
FY24→FY26 trend: Concentration improving marginally as OP and newer doctors grow.
Revenue Lorenz Curves — FY24 · FY25 · FY26
Cumulative % of doctors vs cumulative % of revenue
Top-N Concentration — All 3 Years
% of total revenue from top N doctors
Doctor Tier Distribution
Pillar (≥₹20 Cr) · Growth (₹10–20 Cr) · Active (₹5–10 Cr) · Minor (<₹5 Cr)
Tier
FY24 Count
FY24 Rev ₹Cr
FY24 %
FY25 Count
FY25 Rev ₹Cr
FY25 %
FY26 Count
FY26 Rev ₹Cr
FY26 %
FY24 Cash Mix
73.2%
₹289.8 Cr
FY25 Cash Mix
70.2%
₹287.7 Cr
FY26 Cash Mix
66.2%
₹247.1 Cr YTD
FY26 Insurance Mix
25.7%
₹96 Cr · +3.5pp vs FY24
FY26 Intl Rev
9.2%
FY24: 5.0% → FY25: 7.2%
Govt Mix FY26
5.5%
FY24: 2.5% → rising
💳 Payor Mix Shift — Key Insight
Cash mix declining: 73.2% → 70.2% → 66.2% — a healthy structural shift.
Insurance mix growing: 22.2% → 24.0% → 26.4% — but still well below Apollo's 45% and IHH's ~35%.
International revenue growing strongly: 5.0% → 7.2% → 9.2% — near doubling over 2 years.
Opportunity: ~₹77 Cr incremental revenue if insurance mix matches Apollo (45% vs 26.4%).
Payor Mix — 3-Year Trend
Cash · Insurance · Government · Corporate
Geographic Mix — Domestic vs International
FY24 vs FY25 vs FY26 comparison
📐 Peer Benchmark Overview
LHRC's ARPOB (₹35,188) is 41% below Apollo (₹60,588) and 25% below IHH India (₹47,100) — a significant revenue-per-bed gap.
Bed occupancy at 52% is 16pp below Apollo (68%) and 20pp below IHH (72%). Insurance mix at 26.4% lags Apollo's 45% by 19pp.
ALOS improving to 4.06d — better than IHH 4.2d but still above Apollo's 3.32d.
If LHRC matched Apollo's ARPOB and occupancy: theoretical upside of ₹380 Cr additional revenue.